Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AMAP102 in patients with osteoarthritis
2012-001769-34Phase 2Completed
- Sponsor
- AnaMar
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in osteoarthritis (OA) and hand osteoarthritis comparing AMAP102 with Placebo (2 arms). Primary endpoint: WOMAC Pain subscale for the target knee. Started Jul 2012; status: completed.
02
Drugs
AMAP-102
03
Conditions
osteoarthritis (OA)hand osteoarthritis
Beyond the preview
Go deeper on 2012-001769-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001769-34.